Drug shortage
Bisoprolol Fumarate; Hydrochlorothiazide Tablet · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Jul 26, 2024
Key facts
| Generic name | Bisoprolol Fumarate; Hydrochlorothiazide Tablet |
|---|---|
| Proprietary name | Ziac |
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Ziac, Tablet, 2.5 mg; 6.25 mg (NDC 51285-047-02) |
| Dosage form | Tablet |
| Strength | 2.5 mg 6.25 mg |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 51285-047-02 |
| First posted | Jul 26, 2024 |
| Last updated | Jul 26, 2024 |
| Discontinued | Jul 26, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: